SCHEMBL845046

SCHEMBL845046

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3N3CCCCC3)cc2)cc1)[C@@H]1CCCN1C(=O)c1ccccc1N1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAPT P10636 2/20 0.46
ALDH1A1 P00352 3/20 0.44
MAPK1 P28482 2/20 0.44
TRPV1 Q8NER1 1/20 0.44
HTT P42858 1/20 0.44
NPC1 O15118 2/20 0.44
MEN1 O00255 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RHOC P08134 1/20 0.43
RHOA P61586 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PABPC1 P11940 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10119315 0.91 MAPT (0.40) CYP2C9CYP2C19MAPTALDH1A1MAPK1
SCHEMBL13272378 0.90 MAPT (0.39) CYP2C9CYP2C19MAPTALDH1A1MAPK1
SCHEMBL845013 0.89 CYP2C9 (0.46) CYP2C9CYP2C19MAPTALDH1A1MAPK1
SCHEMBL845008 0.86 ALDH1A1 (0.54) CYP2C9CYP2C19MAPTALDH1A1MAPK1
SCHEMBL845257 0.85 TRPV1 (0.48) CYP2C9CYP2C19MAPTALDH1A1MAPK1
SCHEMBL844996 0.85 CYP2C9 (0.50) CYP2C9CYP2C19ALDH1A1MAPK1TRPV1
SCHEMBL845443 0.85 CYP2C9 (0.47) CYP2C9CYP2C19MAPTALDH1A1MAPK1
SCHEMBL845007 0.83 PABPC1 (0.49) CYP2C9CYP2C19ALDH1A1MAPK1TRPV1
SCHEMBL845131 0.83 PABPC1 (0.49) CYP2C9CYP2C19ALDH1A1MAPK1TRPV1
SCHEMBL845458 0.83 CYP2C9 (0.46) CYP2C9CYP2C19MAPTALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed